NCT02918825View on ClinicalTrials.gov

Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

August 30, 2017

Study Completion Date

September 30, 2017

Conditions
Schizophrenia
Interventions
DRUG

Olanzapine

Olanzapine

DRUG

Paliperidone

Paliperidone

Trial Locations (1)

100096

Beijing HuiLongGuan Hospital, Beijing

All Listed Sponsors
lead

Beijing HuiLongGuan Hospital

OTHER

NCT02918825 - Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia | Biotech Hunter | Biotech Hunter